Clinical Trial: Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults

U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07513168) titled 'Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults' on April 01.

Brief Summary: This prospective, open-label, single-arm, single-center interventional pilot trial aims to evaluate the efficacy and safety of low-dose semaglutide for weight loss and cardiometabolic improvement in obese Pakistani adults without type 2 diabetes mellitus. The study will be conducted at the Asian Institute of Medical Sciences (AIMS), Hyderabad, Sindh, Pakistan. A total of 60 obese adults aged 18 years or older with a body mass index (BMI) of 27.5 kg/m² or greater according to World Health Organization Asian cutoffs and withou...